The mortality rate for trachea, bronchus, or lung malignant neoplasms in Brazil is forecasted to gradually increase from 14.2 to 14.9 deaths per hundred thousand persons between 2024 and 2028. Compared to 2023, where the actual rate was not specified, these projected values suggest a steady rise in mortality rates by roughly 0.1 to 0.2 per year. This translates to an average year-on-year increase of approximately 1.4% based on the given dataset.
Looking ahead, critical trends to monitor include the impact of healthcare interventions, lifestyle changes such as reductions in smoking rates, and advancements in early detection and treatment methods. These factors could influence future mortality trends and progression rates.
